偏头痛和肥胖患者是否接受不同的治疗方法? 从现实世界的数据数据中获得的洞察力
Keshet Pardo1,2, Maor Mermelstein1,2, Gal Tsur1
1Neurology Department, Rabin Medical Center, Petach Tikva, Israel.
Headache
|December 15, 2025
概括
患有肥胖和偏头痛的患者没有得到足够的治疗. 他们收到更多的急性治疗处方,如三类药物和一些预防药物,包括托皮拉和 gabapentinoids.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 肥胖与医疗保健耻辱有关,可能导致诊断不足或治疗不足.
- 患有偏头痛的肥胖患者更有可能使用急性止痛药.
- 关于肥胖偏头痛患者预防性治疗使用的数据有限.
研究的目的:
- 研究在肥胖患者中使用急性和预防性偏头痛治疗的可能性.
- 为了比较偏头痛患者与肥胖患者之间的治疗模式.
主要方法:
- 使用以色列Clalit健康服务数据库进行的回顾性队列研究.
- 倾向性得分对性别和年龄进行匹配.
- 新诊断的偏头痛患者与不肥胖患者的比较 (2020年6月至2023年6月).
主要成果:
- 肥胖的偏头痛患者患有更高的心血管风险因素和精神伴随性疾病.
- 在肥胖患者中增加了接受三药的可能性 (aOR 1.17).
- 在肥胖患者中,托皮拉 (aOR 1.66), gabapentinoids (aOR 1.30) 和duloxetine (aOR 1.42) 的处方率较高,经过对并发症进行调整.
结论:
- 这些发现挑战了在肥胖患者中偏头痛治疗不足的想法.
- 在肥胖患者中观察到急性和某些预防性药物处方的适度增加.
- 进一步的研究可能会探索增加处方率和治疗结果的原因.
相关概念视频
Drug Dosing: Obese Patients
198
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Regression Toward the Mean
6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K


